Titre : Granulomatose avec polyangéite

Granulomatose avec polyangéite : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Granulomatose avec polyangéite : Questions médicales les plus fréquentes", "headline": "Granulomatose avec polyangéite : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Granulomatose avec polyangéite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Granulomatose avec polyangéite" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles", "url": "https://questionsmedicales.fr/mesh/D056648", "about": { "@type": "MedicalCondition", "name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles", "code": { "@type": "MedicalCode", "code": "D056648", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.111.193" } } }, "about": { "@type": "MedicalCondition", "name": "Granulomatose avec polyangéite", "alternateName": "Granulomatosis with Polyangiitis", "code": { "@type": "MedicalCode", "code": "D014890", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Benjamin Terrier", "url": "https://questionsmedicales.fr/author/Benjamin%20Terrier", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France benjamin.terrier@aphp.fr." } }, { "@type": "Person", "name": "Xavier Puéchal", "url": "https://questionsmedicales.fr/author/Xavier%20Pu%C3%A9chal", "affiliation": { "@type": "Organization", "name": "Centre de Référence des Maladies Systémiques Auto-immunes rares, Université Paris Descartes, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France; Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris, France. Electronic address: xavier.puechal@aphp.fr." } }, { "@type": "Person", "name": "Christian Pagnoux", "url": "https://questionsmedicales.fr/author/Christian%20Pagnoux", "affiliation": { "@type": "Organization", "name": "Vasculitis Clinic, Division of Rheumatology, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada." } }, { "@type": "Person", "name": "Roman Yatsyshyn", "url": "https://questionsmedicales.fr/author/Roman%20Yatsyshyn", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine #1, Clinical Immunology and Allergology Named After Academician Ye. M. Neiko, Ivano-Frankivsk National Medical University, Halytska str. 2, Ivano-Frankivsk, 76000, Ukraine." } }, { "@type": "Person", "name": "Olena Zimba", "url": "https://questionsmedicales.fr/author/Olena%20Zimba", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine #2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Changes in Cerebrovascular Procedures and Outcomes During COVID-19 Using the National Surgery Quality Improvement Project.", "datePublished": "2023-06-27", "url": "https://questionsmedicales.fr/article/37385438", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.wneu.2023.06.094" } }, { "@type": "ScholarlyArticle", "name": "Integrated science, technology, engineering, and mathematics project-based learning for physics learning from neuroscience perspectives.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37404578", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyg.2023.1136246" } }, { "@type": "ScholarlyArticle", "name": "Ablation of Projection Glutamatergic Neurons in the Lateral Cerebellar Nuclei Alters Motor Coordination in Vglut2-Cre+ Mice.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37289359", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12311-023-01575-9" } }, { "@type": "ScholarlyArticle", "name": "Future climate projections using the LARS-WG6 downscaling model over Upper Indus Basin, Pakistan.", "datePublished": "2023-06-07", "url": "https://questionsmedicales.fr/article/37284969", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10661-023-11419-y" } }, { "@type": "ScholarlyArticle", "name": "Interaction matters: Bottom-up driver interdependencies alter the projected response of phytoplankton communities to climate change.", "datePublished": "2023-06-02", "url": "https://questionsmedicales.fr/article/37265254", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/gcb.16799" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Maladies auto-immunes", "item": "https://questionsmedicales.fr/mesh/D001327" }, { "@type": "ListItem", "position": 4, "name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles", "item": "https://questionsmedicales.fr/mesh/D056648" }, { "@type": "ListItem", "position": 5, "name": "Granulomatose avec polyangéite", "item": "https://questionsmedicales.fr/mesh/D014890" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Granulomatose avec polyangéite - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Granulomatose avec polyangéite", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Granulomatose avec polyangéite", "description": "Comment diagnostiquer la granulomatose avec polyangéite ?\nQuels tests sanguins sont utilisés pour le diagnostic ?\nQuel rôle joue la biopsie dans le diagnostic ?\nQuels symptômes cliniques orientent vers cette maladie ?\nComment les examens d'imagerie aident-ils au diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014890?mesh_terms=Pilot+Projects&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Granulomatose avec polyangéite", "description": "Quels sont les symptômes courants de cette maladie ?\nLa granulomatose affecte-t-elle les voies respiratoires ?\nQuels problèmes rénaux peuvent survenir ?\nY a-t-il des manifestations cutanées ?\nLes symptômes varient-ils d'un patient à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D014890?mesh_terms=Pilot+Projects&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Granulomatose avec polyangéite", "description": "Peut-on prévenir la granulomatose avec polyangéite ?\nComment éviter les complications ?\nLes vaccinations sont-elles recommandées ?\nY a-t-il des conseils de mode de vie à suivre ?\nLes patients doivent-ils éviter certains médicaments ?", "url": "https://questionsmedicales.fr/mesh/D014890?mesh_terms=Pilot+Projects&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Granulomatose avec polyangéite", "description": "Quels traitements sont utilisés pour cette maladie ?\nComment les corticostéroïdes aident-ils ?\nQuels sont les effets secondaires des traitements ?\nLa thérapie biologique est-elle une option ?\nQuelle est l'importance du suivi médical ?", "url": "https://questionsmedicales.fr/mesh/D014890?mesh_terms=Pilot+Projects&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Granulomatose avec polyangéite", "description": "Quelles sont les complications possibles ?\nComment l'insuffisance rénale se manifeste-t-elle ?\nLes infections sont-elles fréquentes ?\nQuels problèmes pulmonaires peuvent survenir ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D014890?mesh_terms=Pilot+Projects&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Granulomatose avec polyangéite", "description": "Quels sont les facteurs de risque connus ?\nLe tabagisme augmente-t-il le risque ?\nLes infections peuvent-elles déclencher la maladie ?\nY a-t-il un lien avec d'autres maladies auto-immunes ?\nL'âge influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D014890?mesh_terms=Pilot+Projects&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la granulomatose avec polyangéite ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, des biopsies et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la recherche d'anticorps anti-PR3 et des marqueurs d'inflammation." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet d'identifier les granulomes et l'inflammation des vaisseaux." } }, { "@type": "Question", "name": "Quels symptômes cliniques orientent vers cette maladie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs articulaires, des éruptions cutanées et des problèmes respiratoires." } }, { "@type": "Question", "name": "Comment les examens d'imagerie aident-ils au diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les examens comme la radiographie ou l'IRM montrent des anomalies dans les poumons et les reins." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de cette maladie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, perte de poids, et douleurs musculaires." } }, { "@type": "Question", "name": "La granulomatose affecte-t-elle les voies respiratoires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut provoquer des sinusites, des saignements de nez et des toux persistantes." } }, { "@type": "Question", "name": "Quels problèmes rénaux peuvent survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des atteintes rénales peuvent entraîner une insuffisance rénale et des urines anormales." } }, { "@type": "Question", "name": "Y a-t-il des manifestations cutanées ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées, des nodules et des ulcères peuvent apparaître." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'un patient à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la combinaison des symptômes peuvent varier considérablement." } }, { "@type": "Question", "name": "Peut-on prévenir la granulomatose avec polyangéite ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical peut aider." } }, { "@type": "Question", "name": "Comment éviter les complications ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement précoce et un suivi régulier permettent de réduire le risque de complications." } }, { "@type": "Question", "name": "Les vaccinations sont-elles recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent être recommandées pour prévenir certaines infections." } }, { "@type": "Question", "name": "Y a-t-il des conseils de mode de vie à suivre ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est conseillé." } }, { "@type": "Question", "name": "Les patients doivent-ils éviter certains médicaments ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aggraver la maladie et doivent être évités." } }, { "@type": "Question", "name": "Quels traitements sont utilisés pour cette maladie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des corticostéroïdes et des immunosuppresseurs pour réduire l'inflammation." } }, { "@type": "Question", "name": "Comment les corticostéroïdes aident-ils ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils réduisent l'inflammation et soulagent les symptômes rapidement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des infections, des troubles digestifs et des problèmes osseux." } }, { "@type": "Question", "name": "La thérapie biologique est-elle une option ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des thérapies biologiques ciblées peuvent être utilisées pour les cas réfractaires." } }, { "@type": "Question", "name": "Quelle est l'importance du suivi médical ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier est crucial pour ajuster le traitement et surveiller les complications." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance rénale, les infections et les problèmes pulmonaires." } }, { "@type": "Question", "name": "Comment l'insuffisance rénale se manifeste-t-elle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par une diminution de la production d'urine et un gonflement." } }, { "@type": "Question", "name": "Les infections sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients sont plus susceptibles de développer des infections en raison du traitement." } }, { "@type": "Question", "name": "Quels problèmes pulmonaires peuvent survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des complications pulmonaires peuvent inclure des hémorragies et des nodules pulmonaires." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical étroit et des ajustements de traitement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le tabagisme et certaines infections." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque significatif pour cette maladie." } }, { "@type": "Question", "name": "Les infections peuvent-elles déclencher la maladie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections, comme celles des voies respiratoires, peuvent être des déclencheurs." } }, { "@type": "Question", "name": "Y a-t-il un lien avec d'autres maladies auto-immunes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes d'autres maladies auto-immunes peuvent avoir un risque accru." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La maladie est plus fréquente chez les adultes jeunes à moyens, généralement entre 30 et 60 ans." } } ] } ] }

Sources (10000 au total)

Changes in Cerebrovascular Procedures and Outcomes During COVID-19 Using the National Surgery Quality Improvement Project.

Explore the consequences of the coronavirus pandemic (COVID-19) on patients suffering from cerebrovascular disorders necessitating interventions.... Using the National Surgical Quality Improvement Program database, patients with cerebrovascular disease who underwent procedures before (2018-2019) and during (2020-2021) COVID-19 were identified. ICD... There was a significant rise in cerebrovascular accidents (CVAs) (9.96% vs. 12.28%) and a decrease in elective carotid endarterectomies (92.30% vs. 87.22%). Carotid stenting increased significantly (7... The pandemic led to more severe disease progression and reduced diagnoses due to screening delays, indicating deferred care. Prolonged operative times, extended hospital stays, and worsening outcomes,...

The Godmother Project: A Virtual Initiative to Support Pregnant and Postpartum Women in Brazil During the COVID-19 Pandemic.

The COVID-19 pandemic increased maternal distress and demand for social support and educational services, while restriction measures decreased the availability of these services.... The Godmother Project, a person-centered, WhatsApp-based support and health education initiative, was created after all in-person perinatal educational activities offered at 3 Brazilian hospitals were... The project provides direct communication between WhatsApp groups of 25-30 pregnant/postpartum women and a Godmother. It also offers access to a virtual library of educational materials prepared in re... Our findings suggest that WhatsApp groups of pregnant/postpartum women led by dedicated nurse educators can be an important tool to educate and support women during the perinatal period. This type of ...

The next phases of the Migrante Project: Study protocol to expand an observatory of migrant health on the Mexico-U.S. border.

Mexican migrants traveling across the Mexico-United States (U.S.) border region represent a large, highly mobile, and socially vulnerable subset of Mexican nationals. Population-level health data for ... In the next phases, two probability, face-to-face surveys of Mexican migrant flows will be conducted at key crossing points in Tijuana, Ciudad Juarez, and Matamoros (... Interview and biometric data from the Migrante project will help to characterize health care access and health status and identify variations in NCD-related outcomes, mental health, and substance use ...

Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy.

Epigenetic clocks estimate chronologic age using methylation levels at specific loci. We tested the hypothesis that accelerated epigenetic aging is associated with abnormal values in a range of clinic... The Project Baseline Health Study recruited 2502 participants, including 1661 with epigenetic age estimates from the Horvath pan-tissue clock. We classified individuals with extreme values as having e... The EAA (n=188) and epigenetic age deceleration (n=195) groups were identified as having EAA estimates ≥5 years or ≤-5 years, respectively. In primary analyses, individuals with EAA had higher values ... We report multiple cardiometabolic, hematologic, and physical function features characterizing individuals with EAA. These highlight factors that may mediate the adverse effects of aging and identify ... URL: https://www.... gov; Unique identifier: NCT03154346....

Palliative care teaching in the new internal medicine curriculum: Project ECHO-an innovative approach to postgraduate education.

The Internal Medicine Training (IMT) Programme is an evolution of Core Medical Training introduced in 2019. The IMT curriculum places an increased emphasis on palliative care; however, access to palli... The Project ECHO training programme involved multipoint video technology, telementoring, expert talks and case-based discussions over six sessions, and was fully mapped to the palliative care componen... By creating a community of practice, we provided virtual placements and over 9 hours of virtual direct contact with palliative medicine consultants; and in total, 921 individual attendances occurred, ... Project ECHO is an effective method of delivering teaching to trainees across a large geographical area. Course evaluation shows outstanding results in trainee satisfaction, confidence, knowledge, pat...